Ballermann B J, Brenner B M
Circ Res. 1986 May;58(5):619-30. doi: 10.1161/01.res.58.5.619.
Extracts of mammalian atria, but not ventricles, induce marked diuresis, natriuresis, and reduction in blood pressure when infused systemically in rats and dogs. These extracts also inhibit aldosterone biosynthesis and renal renin release. Natriuretic peptides, 21 amino acids and longer, have been isolated from atria of rodents and man, and share a nearly homologous amino acid sequence at the carboxyterminus. Natriuretic activity resides in a 17-amino acid ring formed by a disulfide bridge, and the C-terminal Phe-Arg appears necessary for full biological potency. The deoxyribonucleic acid-encoding atrial natriuretic peptides have been cloned and the gene structure elucidated. Reduction of the diuretic and natriuretic responses to an acute volume load by right atrial appendectomy first suggested a role for atrial peptides in the physiological response to plasma volume expansion. Subsequently, release of peptides with natriuretic and spasmolytic properties from isolated heart preparations in response to right atrial distension was demonstrated by bioassay and radioimmunoassay. The presence of these peptides in normal rat and human plasma in concentrations of 20-100 pM, and the findings of increased levels in response to acute and chronic plasma volume expansion, rapid atrial tachyarrhythmias, systemic hypertension, congestive heart failure, and renal insufficiency imply that they play an important role in body fluid homeostasis. The mechanisms by which atrial peptides increase renal salt and water excretion are as yet unclear. Renal vascular effects have been consistently demonstrated, and limited evidence for direct actions on tubule ion transport has also been reported recently. In vitro, these peptides cause precontracted vascular and nonvascular smooth muscle to relax, mediated by a direct action on smooth muscle cells. Specific receptors for these peptides have been characterized in crude membranes prepared from whole kidney homogenates and adrenal glomerulosa cells, in intact glomeruli and cultured glomerular mesangial cells, and in intact bovine aortic smooth muscle and endothelial cells. Natriuretic peptides stimulate cyclic guanosine monophosphate accumulation in target tissues, and augment particulate guanylate cyclase activity in membrane fractions, suggesting that cyclic guanosine monophosphate is the second messenger mediating their cellular action.
当将哺乳动物心房而非心室的提取物经全身注入大鼠和狗体内时,会引起显著的利尿、利钠以及血压降低。这些提取物还会抑制醛固酮的生物合成和肾脏肾素的释放。已从啮齿动物和人类的心房中分离出21个氨基酸及更长的利钠肽,并且它们在羧基末端具有近乎同源的氨基酸序列。利钠活性存在于由二硫键形成的17个氨基酸的环中,并且C末端的苯丙氨酸-精氨酸对于充分的生物活性似乎是必需的。编码心房利钠肽的脱氧核糖核酸已被克隆,其基因结构也已阐明。右心耳切除术降低了对急性容量负荷的利尿和利钠反应,这首先提示心房肽在对血浆容量扩张的生理反应中起作用。随后,通过生物测定和放射免疫测定证明,在离体心脏制剂中,响应右心房扩张会释放出具有利钠和解痉特性的肽。这些肽在正常大鼠和人类血浆中的浓度为20 - 100 pM,并且在急性和慢性血浆容量扩张、快速房性心律失常、系统性高血压、充血性心力衰竭和肾功能不全时水平升高的发现表明它们在体液平衡中起重要作用。心房肽增加肾脏盐和水排泄的机制尚不清楚。肾血管效应一直得到证实,并且最近也报道了对肾小管离子转运直接作用的有限证据。在体外,这些肽通过对平滑肌细胞的直接作用,使预先收缩的血管和非血管平滑肌舒张。这些肽的特异性受体已在由全肾匀浆和肾上腺球状带细胞制备的粗膜、完整的肾小球和培养的肾小球系膜细胞以及完整的牛主动脉平滑肌和内皮细胞中得到表征。利钠肽刺激靶组织中环鸟苷酸的积累,并增强膜部分中的颗粒型鸟苷酸环化酶活性,这表明环鸟苷酸是介导其细胞作用的第二信使。